Korro Bio (KRRO) could rise as Zacks upgraded the stock to a Rank #2 (Buy), signaling improving earnings optimism. The note is positive but based on analyst positioning rather than a reported earnings beat.
Korro Bio (KRRO) could rise as Zacks upgraded the stock to a Rank #2 (Buy), signaling improving earnings optimism. The note is positive but based on analyst positioning rather than a reported earnings beat.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
